Aeromonas　species are ubiquitous water borne medically important, Gram-negative, rod-shaped micro-organisms [1]. Today, they are regarded not only as disease-causing pathogen of fish but are also responsible for variety of complications in both immunocompetent and immunocompromised humans [2]. Aeromonas have gained importance as human pathogens causing gastrointestinal infections. They also cause extraintestinal infections such as cellulitis, wound infections, sepsis and urinary tract infections [1]. Deodhar, et al. [3] isolated Aeromonas from 45 (1.8%) of 2,480 patients with acute gastroenteritis. Out of 863 traveller’s diarrhea patients returning from Asia, Africa, and Latin America, 2% of cases were caused by　Aeromonas　[4]. Studies have shown that three Aeromonas (A. hydrophila, A. caviae and　A. veronii　bv Sobria) are responsible for ≥85% of human infections [2]. Clinical spectrum of Aeromonas-induced diarrhoea varies from toxigenic diarrhea to colitis and in developing countries it is predominantly toxigenic [3]. The most common presentation for　 Aeromonas gastroenteritis is secretory(watery) enteritis suggesting the toxigenic nature of the organism [2]. Aeromonas　strains are almost universally susceptible to fluoroquinolones and exhibited multidrug resistance [2]. Bhowmika, et al. [1] isolated potentially pathogenic and multi-drug-resistant strains of　 A. hydrophila from natural surface waters, and showed its ability to produce virulence-associated factors similar to that in clinical isolates thereby indicating a significant risk to public health [1]. To conclude, Aeromonas associated gastroenteritis in children mimics cholera and the presence of this emerging organism should be kept in mind while treating acute gastroenteritis.